Abstract
Liver biopsy interpretation continues to play an integral role in diagnosis and management of most forms of liver disease. In this review, the common histopathologic features of the more commonly encountered processes, chronic hepatitis, autoimmune hepatitis, and chronic cholestatic liver diseases, are discussed. In addition, areas of ongoing investigation and controversy, including steatohepatitis and dysplasia, are reviewed. Finally, the pathology of adult metabolic liver disease, drug-induced liver disease, and various miscellaneous disease processes, including venous outflow obstruction, acute fatty liver of pregnancy, and fulminant hepatic failure, are reviewed.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References and Recommended Reading
Bacon, BR, Olynyk, JK, Brunt, EM, et al.: HFE genotype in patients with hemochromatosis and other liver diseases. Ann Intern Med 1999, 130:953–962. This study was comprised of 66 patients with hereditary hemochromatosis and 132 patients with other forms of liver disease who were carefully analyzed with routine liver chemistries, iron studies, HFE genotype, and liver biopsy. The study shows the usefulness of genotype analysis in patients with liver disease and overload and provides an algorithm for clinical evaluation of hemochromatosis with laboratory parameters and genetic testing. The use of liver biopsy in this patient population is discussed.
Knodell RG, Ishak KG, Black WC, et al.: Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1981, 1:431–435.
Scheuer PJ.: Classification of chronic viral hepatitis: a need for reassessment. J Hepatol 1991, 13:372–374.
Ishak K, Baptista A, Bianchi L, et al.: Histological grading and staging of chronic hepatitis. J Hepatol 1995, 22:696–699.
French METAVIR Cooperative Study Group: Intraobserver and interobserver variations in liver biopsies in patients with chronic hepatitis C. Hepatology 1994, 20:15–20.
Bedossa P, Poynard T, and the French METAVIR Cooperative Study Group: An algorithm for grading activity in chronic hepatitis C. Hepatology 1996, 24:289–293.
Bach N, Thung SN, Schaffner F: The histological features of chronic hepatitis C and autoimmune chronic hepatitis: a comparative analysis. Hepatology 1992, 15:572–577.
Czaja AJ, Carpenter HA: Histological findings in chronic hepatitis C with autoimmune features. Hepatology 1997, 26:459–466.
Kim WR, Ludwig J, Lindor KD: Variant forms of cholestatic diseases involving small bile ducts in adults. Am J Gastroenterol, 1999, in press. In this review, the authors discuss the literature and the experience of the Mayo Clinic in adult patients with chronic cholestatic liver disease due to processes of the small bile ducts. The focus of the review is on patients encountered in the outpatient setting. Current understanding of etiology, course of disease, and treatment options are given.
Czaja AJ.: The variant forms of autoimmune hepatitis. Ann Int Med 1996, 125:588–598.
International Working Party:Terminology of nodular hepatocellular lesions. Hepatology 1995, 22:983–993. A thorough review of the growing understanding of steatohepatitis. Patient characteristics, clinical evaluation of suspected patients, histopathology, mechanisms of liver injury, and current treatment recommendations are discussed.
Brunt, EM, Janney, CJ, Di Bisceglie, et al.: Non-alcoholic steatohepatitis: a proposal for grading and staging the histologic lesions. Am J Gastroenterol 1999, 94:2467–2474. The study reported here was done by retrospective review of liver biopsies from 51 well-characterized patients with nonalcoholic steatohepatitis in order to derive a systematic method of reporting severity of necroinflammation (grade) and fibrosis (stage). All of the previously recognized histopathologic features of steatohepatitis were separately analyzed; the final method of grading and staging is based on the lesions identified as most significant, and includes steatosis, lobular inflammation, liver cell ballooning, and the extent of perisinusoidal and portal fibrosis.
International Working Party: Terminology of nodular hepatocellular lesions. Hepatology 1995, 22:983–993.
Tiniakos DG, Brunt EM: Proliferating cell nuclear antigen and Ki-67 labeling in hepatocellular nodules: a comparative study. Liver 1999, 19:58–68.
Deugnier YM, Charalambous P, LeQuillenc D, et al.:Preneoplastic significance of hepatic iron free foci in genetic hemochromatosis: a study of 185 patients. Hepatology 1993, 18:1363–1369.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Brunt, E.M. Liver biopsy interpretation for the gastroenterologist. Curr Gastroenterol Rep 2, 27–32 (2000). https://doi.org/10.1007/s11894-000-0048-2
Issue Date:
DOI: https://doi.org/10.1007/s11894-000-0048-2